Operator: Greetings, and welcome to the Fourth Quarter and Year-end 2022 Maravai LifeSciences Earnings Conference Call. Please note that this conference is being recorded.
22.02.2023 - Base business revenues, excluding COVID-19 related CleanCap revenues, were up 67% in the fourth quarter and up 17% for the full year Announces acquisition of privately-held Alphazyme, LLC, adding critical enzyme manufacturing capabilities to .
/PRNewswire/ EverGlade Consulting ("EverGlade"), a national consulting firm, has successfully partnered with a global leader in mRNA materials used for.
04.08.2022 - Record First Half Revenue, EBITDA, Adjusted EBITDA and EPSSAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) - Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech .
Maravai LifeSciences (NASDAQ:MRVI – Get Rating) and Clever Leaves (NASDAQ:CLVR – Get Rating) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, risk, dividends, earnings and institutional ownership. Analyst Recommendations This is a summary of current ratings and […]